Quantum BioPharma Ltd. (CSE:QNTM)
Canada flag Canada · Delayed Price · Currency is CAD
4.510
+0.410 (10.00%)
At close: Sep 4, 2026

Quantum BioPharma Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
364010474053
Market Cap Growth
-56.35%301.84%-78.80%18.00%-24.98%39.98%
Enterprise Value
304104284
Last Close Price
4.5110.505.2078.0067.6085.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.215.760.672.770.970.78
P/TBV Ratio
7.0512.181.064.541.601.11

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.160.370.080.030.020.01
Net Debt / Equity Ratio
-0.47-0.10-0.61-0.25-0.54-0.64
Net Debt / EBITDA Ratio
0.250.030.410.190.721.17
Net Debt / FCF Ratio
0.530.060.930.290.581.68
Quick Ratio
0.480.431.652.392.224.13
Current Ratio
1.201.071.812.432.285.28
Return on Equity (ROE)
-621.46%-346.87%-127.76%-83.91%-63.08%-75.05%
Return on Assets (ROA)
-51.84%-67.64%-58.31%-43.02%-33.82%-40.20%
Return on Capital Employed (ROCE)
-202.00%-299.90%-154.60%-149.00%-89.70%-62.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-97.95%-89.14%-203.95%-50.03%-79.79%-83.66%
FCF Yield
-20.81%-28.05%-98.75%-30.26%-96.15%-49.19%
Buyback Yield / Dilution
-114.18%-189.01%-86.67%-2.21%-10.84%-190.15%